Marcos Castanheira Alegria

Marcos Castanheira Alegria has extensive experience in the biotechnology and pharmaceutical sectors, currently serving as the Director of R&D for Institutional Market at Hypera since August 2021. Prior to this role, significant contributions were made at Cristália Produtos Químicos Farmacêuticos Ltda from October 2007 to August 2021, where positions held included Director of Biotechnology, General Manager of Biotechnology, Scientific Manager of Biotechnology, Scientific Supervisor, and Senior Researcher. Earlier career roles included Senior Researcher at Alellyx Applied Genomics from April 2003 to September 2007 and Scientific Advisor at LabTrade do Brasil from July 1996 to March 1997. Educational background includes a Doctorate in Biochemistry and Biotechnology from USP - Universidade de São Paulo, a Master's in Biotechnology from Universidade Estadual Paulista Júlio de Mesquita Filho, and a Bachelor's in Chemistry from Universidade Estadual Paulista Júlio de Mesquita Filho. Additionally, a technical education was completed at Colégio Técnico Integrado in Amparo-SP.